Skip to content
CRDF Cardiff Oncology, Inc. Common Stock
$0.87 -1.73% -0.02
Notify me if price changes either direction
Interactive Brokers Logotype

Buy CRDF stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 60.8M
Enterprise value 46.9M
Trailing PE -1.2665217391304
Forward PE -1.6523342
PEG Ratio 0.12665217391304
Enterprise to EBITDA -0.996
Enterprise to revenue 89.313
Price to book MRQ 2.6476378
Price to sales TTM 175.15717

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-03-31
Revenue (TTM) 525.0K
EBITDA -47070000
Diluted EPS TTM -0.69
Total Cash (MRQ) 46.1M
Current ratio (MRQ) 3.273
Operating Cash Flow (TTM) -37417000

CRDF trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent CRDF News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.